Precision medicine is hailed as a new revolution in health care and with good reason. The ability to gather information about an individual patient and to tailor a customised treatment accordingly marks a paradigm shift in the way that medicine is carried out.

We work with innovators in sequencing, genomics, proteomics, metabolomics and cell biology, as well as bioinformatics, biosensors and artificial intelligence, all of which play a part in this exciting field of precision medicine.

We also have huge experience of IP strategies for protecting the use of biomarkers to characterize patients and determine the best drug treatments. Indeed, we have shaped the case law that makes the European Patent Office such a favorable forum for protecting these inventions. 

We understand the challenges in this area and can advise you on how to adapt your IP strategy to deal with these. For example, while the EPO is a very favorable jurisdiction for protecting inventions in the precision medicine space, over the last few years the USPTO has become a much more difficult forum (following the US Supreme Court’s 2013 Prometheus and Myriad decisions). We can advise on the international landscape and we work with trusted international partners to shape strategies with the best chance of success.

We also appreciate that methods of diagnosis are increasingly performed across international borders, with samples sent internationally to centralised processing facilities and data flowing between jurisdictions. This can cause difficulties in enforcing patents and should therefore be considered carefully at the early stages of the patent process. We recognise the importance of understanding how the technology will be implemented and can work with you to design an IP strategy which will reflect and protect the situation in the real world.


Find out more about protecting your innovations


Precision Medicine: the next revolution in healthcare

In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in genetic analysis, molecular biology and cell science, we now know more about the human condition than ever before. This wealth of information opens the door for the next revolution in medicine – treatments that are truly personalised for each patient.

Find out more

Precision medicine: ethics, regulation and patent law

New genomic and proteomic analysis technologies allow for diagnosis and prognosis of patients with greater accuracy than ever before. Indeed, due to the substantial amount of research now undertaken in this space, we are now able to identify new disease states and conditions previously unknown or poorly understood, allowing early detection and treatment of disease.

Find out more

Gender medicine – deriving novelty from treating women

When you hear the term “gender medicine”, what comes to mind? For many people, the term is associated with reproductive health issues, such as pregnancy, genitourinary medicine, or endocrinology. However, researchers are increasingly aware that all medicine is, to some extent, influenced by sex and gender.

Learn More

We work at every stage of the IP lifecycle


Drafting, Filing & Prosecution
Portfolio Management
Searching & Watching
Renewals & EP Validations

Read More


Pre-action Advice
Oppositions & Appeals
Alternative Dispute Resolution

Read More


Strategic Advice
Commercial Issues
Corporate Support

Read More

Mewburn Ellis


Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.